921 related articles for article (PubMed ID: 33669619)
1. Organoid and Spheroid Tumor Models: Techniques and Applications.
Gunti S; Hoke ATK; Vu KP; London NR
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669619
[TBL] [Abstract][Full Text] [Related]
2. Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine.
Gilazieva Z; Ponomarev A; Rutland C; Rizvanov A; Solovyeva V
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977530
[TBL] [Abstract][Full Text] [Related]
3. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.
Zhou Z; Cong L; Cong X
Front Oncol; 2021; 11():762184. PubMed ID: 35036354
[TBL] [Abstract][Full Text] [Related]
4. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
5. Microtechnology-based methods for organoid models.
Velasco V; Shariati SA; Esfandyarpour R
Microsyst Nanoeng; 2020; 6():76. PubMed ID: 34567686
[TBL] [Abstract][Full Text] [Related]
6. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
Qu J; Kalyani FS; Liu L; Cheng T; Chen L
Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
[TBL] [Abstract][Full Text] [Related]
7. Personalized Cancer Medicine: An Organoid Approach.
Aboulkheyr Es H; Montazeri L; Aref AR; Vosough M; Baharvand H
Trends Biotechnol; 2018 Apr; 36(4):358-371. PubMed ID: 29366522
[TBL] [Abstract][Full Text] [Related]
8. Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling.
Kim SK; Kim YH; Park S; Cho SW
Acta Biomater; 2021 Sep; 132():37-51. PubMed ID: 33711526
[TBL] [Abstract][Full Text] [Related]
9. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
[TBL] [Abstract][Full Text] [Related]
10. Organoid Models for Precision Cancer Immunotherapy.
Sun CP; Lan HR; Fang XL; Yang XY; Jin KT
Front Immunol; 2022; 13():770465. PubMed ID: 35450073
[TBL] [Abstract][Full Text] [Related]
11. Farm and Companion Animal Organoid Models in Translational Research: A Powerful Tool to Bridge the Gap Between Mice and Humans.
Kawasaki M; Goyama T; Tachibana Y; Nagao I; Ambrosini YM
Front Med Technol; 2022; 4():895379. PubMed ID: 35647577
[TBL] [Abstract][Full Text] [Related]
12. Organoid technology and applications in cancer research.
Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
[TBL] [Abstract][Full Text] [Related]
13. Organoid models in gynaecological oncology research.
Semertzidou A; Brosens JJ; McNeish I; Kyrgiou M
Cancer Treat Rev; 2020 Nov; 90():102103. PubMed ID: 32932156
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in organoid engineering: A comprehensive review.
Unagolla JM; Jayasuriya AC
Appl Mater Today; 2022 Dec; 29():. PubMed ID: 38264423
[TBL] [Abstract][Full Text] [Related]
15. Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.
Colella G; Fazioli F; Gallo M; De Chiara A; Apice G; Ruosi C; Cimmino A; de Nigris F
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29466296
[TBL] [Abstract][Full Text] [Related]
16. Constrained spheroids/organoids in perfusion culture.
Lee F; Iliescu C; Yu F; Yu H
Methods Cell Biol; 2018; 146():43-65. PubMed ID: 30037466
[TBL] [Abstract][Full Text] [Related]
17. Organoid models of the tumor microenvironment and their applications.
Xia T; Du WL; Chen XY; Zhang YN
J Cell Mol Med; 2021 Jul; 25(13):5829-5841. PubMed ID: 34033245
[TBL] [Abstract][Full Text] [Related]
18. [Advances in three-dimensional tumor models for colorectal cancer].
Wang CT; Zhou JL; Lin GL; Yin SY; Cong L; Zhang GN; An Y; Qiu XY
Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):464-470. PubMed ID: 37355464
[TBL] [Abstract][Full Text] [Related]
19. Establishment of Organoids From Human Epithelioid Sarcoma With the Air-Liquid Interface Organoid Cultures.
Wakamatsu T; Ogawa H; Yoshida K; Matsuoka Y; Shizuma K; Imura Y; Tamiya H; Nakai S; Yagi T; Nagata S; Yui Y; Sasagawa S; Takenaka S
Front Oncol; 2022; 12():893592. PubMed ID: 35677170
[TBL] [Abstract][Full Text] [Related]
20. 3D Tumor Models and Their Use for the Testing of Immunotherapies.
Boucherit N; Gorvel L; Olive D
Front Immunol; 2020; 11():603640. PubMed ID: 33362787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]